HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL
Kevin O. McNerney(Northwestern University), Liora M. Schultz(Columbia University Irving Medical Center), Christina Baggott(Stanford University), Michael R. Verneris(NHS Blood and Transplant), Christa Krupski(Cincinnati Children's Hospital Medical Center), Samuel John(Southwestern Medical Center), T. Laetsch(Children's Hospital of Philadelphia), Gary Douglas Myers(Baylor College of Medicine), Aimee C. Talleur(St. Jude Children's Research Hospital), L. Nelson Sanchez‐Pinto(Lurie Children's Hospital), Elliot Stieglitz(UCSF Benioff Children's Hospital), Vanessa A. Fabrizio(Children's Hospital Colorado), Muna Qayed(Emory University), Lena E. Winestone(University of California, San Francisco), Prakash Satwani(Pediatrics and Genetics), Challice L. Bonifant(Johns Hopkins University), Soyang Kwon(Northwestern University), Anant Vatsayan(Children's National), Susanne H.C. Baumeister(Dana-Farber Cancer Institute), Xiaopei Lily Zeng(Northwestern University), Rebecca Gardner(Seattle Children's Hospital), Snehit Prabhu(Stanford University), Jenna Rossoff(Lurie Children's Hospital), Nicole Karras(City Of Hope National Medical Center), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy), Gabriela Llaurador Caraballo(Baylor College of Medicine), Christine L. Phillips(Cincinnati Children's Hospital Medical Center), Swati Naik(St. Jude Children's Research Hospital), Julie-An M. Talano(Medical College of Wisconsin), Amy Moskop(Medical College of Wisconsin), Emily Egeler(Palo Alto University), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Amy K. Keating(Boston Children's Hospital), Holly Pacenta(Children's Hospital Colorado)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577